ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
-0,50%
Bitcoin
66.990,39
-0,13%
Brent Oil
83,76
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. AMEX
  6. NovaBay Pharmaceuticals Inc New (NBY)

  7. NovaBay Pharmaceuticals Inc New (NBY) Notícias

NBY

NovaBay Pharmaceuticals (NBY)

NovaBay Pharmaceuticals Inc New
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AMEX:NBY
DataHoraFonteTítuloCódigoCompanhia
13/05/202409:30Business WireNovaBay Pharmaceuticals Launches Avenova Product Bundles for Individualized Relief from Multifactorial Dry Eye SymptomsAMEX:NBYNovaBay Pharmaceuticals Inc New
09/05/202417:05Business WireNovaBay Pharmaceuticals Reports First Quarter 2024 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
07/05/202409:00Business WireNovaBay Pharmaceuticals Announces Record Ordered Product Sales of Avenova-Branded Products in April through AmazonAMEX:NBYNovaBay Pharmaceuticals Inc New
03/05/202407:50Business WireNovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
22/04/202407:57Business WireNovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova SalesAMEX:NBYNovaBay Pharmaceuticals Inc New
19/04/202419:00Business WireNovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder EquityAMEX:NBYNovaBay Pharmaceuticals Inc New
17/04/202407:59Business WireNovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing ExpensesAMEX:NBYNovaBay Pharmaceuticals Inc New
26/03/202417:05Business WireNovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
25/03/202419:38Business WireNovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024AMEX:NBYNovaBay Pharmaceuticals Inc New
14/03/202409:00Business WireNovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023AMEX:NBYNovaBay Pharmaceuticals Inc New
14/02/202416:52Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:NBYNovaBay Pharmaceuticals Inc New
30/01/202411:00Business WireNovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based SalesAMEX:NBYNovaBay Pharmaceuticals Inc New
10/01/202410:00Edgar (US Regulatory)Form 8-K - Current reportAMEX:NBYNovaBay Pharmaceuticals Inc New
09/01/202411:15Business WireNovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor NetworkAMEX:NBYNovaBay Pharmaceuticals Inc New
04/01/202413:50Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:NBYNovaBay Pharmaceuticals Inc New
06/12/202308:50Business WireNovaBay Pharmaceuticals Partners with Woo University to Educate Eyecare Professionals on the Use of Amniotic MembranesAMEX:NBYNovaBay Pharmaceuticals Inc New
09/11/202318:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:NBYNovaBay Pharmaceuticals Inc New
09/11/202318:05Business WireNovaBay Pharmaceuticals Reports Third Quarter 2023 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
02/11/202307:50Business WireNovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023AMEX:NBYNovaBay Pharmaceuticals Inc New
11/10/202309:00Business WireNovaBay Pharmaceuticals Expands Physician Dispensed Sales Channel with New Avenova ProgramsAMEX:NBYNovaBay Pharmaceuticals Inc New
02/10/202307:50Business WireNovaBay Pharmaceuticals to Present at the Dawson James Small Cap Growth ConferenceAMEX:NBYNovaBay Pharmaceuticals Inc New
21/09/202310:35GlobeNewswire Inc.Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceAMEX:NBYNovaBay Pharmaceuticals Inc New
14/09/202309:00Business WireNovaBay Pharmaceuticals Announces Commercial Launch of Avenova® AllograftAMEX:NBYNovaBay Pharmaceuticals Inc New
11/09/202309:00Business WireNovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® AllograftAMEX:NBYNovaBay Pharmaceuticals Inc New
10/08/202317:05Business WireNovaBay Pharmaceuticals Reports Second Quarter 2023 Financial ResultsAMEX:NBYNovaBay Pharmaceuticals Inc New
08/08/202317:05Business WireNovaBay Pharmaceuticals to Hold Second Quarter 2023 Conference Call on August 10, 2023AMEX:NBYNovaBay Pharmaceuticals Inc New
14/07/202309:30Business WireNovaBay Pharmaceuticals Reports Record Avenova Sales DayAMEX:NBYNovaBay Pharmaceuticals Inc New
10/07/202307:50Business WireNovaBay Pharmaceuticals Announces Exclusive Amazon Prime Day 2023 Promotions on All Avenova-Branded ProductsAMEX:NBYNovaBay Pharmaceuticals Inc New
28/06/202307:50Business WireNovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Educational Programs and Avenova Product PromotionsAMEX:NBYNovaBay Pharmaceuticals Inc New
20/06/202307:50Business WireNovaBay Pharmaceuticals to Showcase its Full Line of Avenova Eyecare Products at the 126th Annual American Optometric Association CongressAMEX:NBYNovaBay Pharmaceuticals Inc New
 Apresentando as notícias mais relevantes sobre:AMEX:NBY

Seu Histórico Recente

AMEX
FAPR
FT Vest US Equity Buffer...
ASX
TZNN
BIT
P1T5U7
BNP Paribas Issuance
USOTC
GRRB
Grandsouth Bancorporation (QX)
USOTC
ENCTD
Encanto Potash (CE)
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados